Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04279067 · ClinicalTrials.gov registry record · NA
BCI-FES Therapy for Stroke Rehabilitation
A NA study, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT04279067 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 62 participants.
The verdict
NCT04279067, a NA study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
There are over 7 million stroke survivors in the US alone, with approximately 795,000 new cases annually. Despite the best available physiotherapy, 30-60% of stroke survivors remain affected by difficulty walking, with foot weakness often being the main cause. Given that post-stroke gait impairments remain poorly addressed, new methods that can provide lasting improvements are necessary. Brain-computer interface (BCI) technology may be one such novel approach. BCI technology enables "direct brain control" of external devices such as assistive devices and prostheses by translating brain waves into control signals. When BCI systems are integrated with functional electrical stimulation (FES) systems, they can be used to deliver a novel physical therapy to improve movement after stroke. BCI-FES systems are hypothesized to stimulate recovery after stroke beyond that of conventional physical therapy.
Interventions
- DEVICE BCI-FES dorsiflexion therapy
- BEHAVIORAL Physiotherapy one hour
- BEHAVIORAL Physiotherapy two hours
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-05-15 |
| Est. Completion | 2024-11-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04279067
The ClinicalTrials.gov registry entry for NCT04279067 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which BCI-FES dorsiflexion therapy is the first listed.
NCT04279067 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04279067 about?
NCT04279067 is a clinical study titled "BCI-FES Therapy for Stroke Rehabilitation". There are over 7 million stroke survivors in the US alone, with approximately 795,000 new cases annually. Despite the best available physiotherapy, 30-60% of stroke survivors remain affected by difficulty walking, with foot weakness often being the main cause. Given that post-stroke gait impairments...
What is the current status of trial NCT04279067?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2020-05-15. Estimated completion is 2024-11-26.
What interventions are being tested in trial NCT04279067?
The interventions under investigation include: BCI-FES dorsiflexion therapy (DEVICE), Physiotherapy one hour (BEHAVIORAL), Physiotherapy two hours (BEHAVIORAL).
Who is sponsoring clinical trial NCT04279067?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.